Skip to main content
Top
Published in: Supportive Care in Cancer 2/2013

01-02-2013 | Original Article

In-advance end-of-life discussions and the quality of inpatient end-of-life care: a pilot study in bereaved primary caregivers of advanced cancer patients

Authors: Masanori Mori, Donna Ellison, Takamaru Ashikaga, Ursula McVeigh, Allan Ramsay, Steven Ades

Published in: Supportive Care in Cancer | Issue 2/2013

Login to get access

Abstract

Purpose

Advanced cancer care planning is encouraged to achieve individualized care. We hypothesized that in-advance end-of-life (EOL) discussions and establishment of do-not-resuscitate (DNR) status prior to the terminal admission would be associated with better quality of inpatient EOL care.

Methods

We conducted a post-mortality survey, utilizing the validated Toolkit of Instruments to Measure End-of-Life Care. Primary caregivers (PCGs) of the advanced cancer patients who died at our institution between January 2009 and December 2010 were contacted more than 3 months after the patients’ death. The endpoints included overall score for EOL care (0–10; 10 = best care), problem scores of six domains (0–1; 1 = worst problem), and score for supporting family’s self-efficacy (knowing what to expect/do during the dying process) (1–3; 3 = greatest support).

Results

Of 115 PCGs contacted, 50 agreed to participate (43.5 %). Patients with EOL discussions (n = 20), as compared to those without (n = 29), had higher rating of overall EOL care (9.7 vs. 8.7; p = 0.001): lower problem scores in “informing and promoting shared decision-making” (0.121 vs. 0.239; p = 0.007), “encouraging advanced care planning” (0.033 vs. 0.167; p = 0.010), “focusing on individual” (0.051 vs. 0.186; p = 0.014), “attending to emotional/spiritual needs of family” (0.117 vs. 0.333; p = 0.010), and “providing care coordination” (0.100 vs. 0.198; p = 0.032), and greater support for family’s self-efficacy (2.734 vs. 2.310; p < 0.001). No significant differences were found in these outcomes between patients with DNR (n = 19) and those with full code (n = 31) on admission.

Conclusion

Advanced cancer patients may receive higher quality of inpatient EOL care if they had in-advance EOL discussions.
Literature
1.
go back to reference Nilsson ME, Maciejewski PK, Zhang B et al (2009) Mental health, treatment preferences, advance care planning, location, and quality of death in advanced cancer patients with dependent children. Cancer 115:399–409PubMedCrossRef Nilsson ME, Maciejewski PK, Zhang B et al (2009) Mental health, treatment preferences, advance care planning, location, and quality of death in advanced cancer patients with dependent children. Cancer 115:399–409PubMedCrossRef
2.
go back to reference Teno JM, Clarridge B, Casey V, Edgman-Levitan S, Fowler J (2001) Validation of Toolkit After-Death Bereaved Family Member Interview. J Pain Symptom Manage 22:752–758PubMedCrossRef Teno JM, Clarridge B, Casey V, Edgman-Levitan S, Fowler J (2001) Validation of Toolkit After-Death Bereaved Family Member Interview. J Pain Symptom Manage 22:752–758PubMedCrossRef
3.
go back to reference Teno JM, Clarridge BR, Casey V, Welch LC, Wetle T, Shield R, Mor V (2004) Family perspectives on end-of-life care at the last place of care. JAMA 291:88–93PubMedCrossRef Teno JM, Clarridge BR, Casey V, Welch LC, Wetle T, Shield R, Mor V (2004) Family perspectives on end-of-life care at the last place of care. JAMA 291:88–93PubMedCrossRef
4.
go back to reference Wright AA, Zhang B, Ray A et al (2008) Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 300:1665–1673PubMedCrossRef Wright AA, Zhang B, Ray A et al (2008) Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 300:1665–1673PubMedCrossRef
5.
go back to reference Levin TT, Li Y, Weiner JS, Lewis F, Bartell A, Piercy J, Kissane DW (2008) How do-not-resuscitate orders are utilized in cancer patients: timing relative to death and communication-training implications. Palliat Support Care 6:341–348PubMedCrossRef Levin TT, Li Y, Weiner JS, Lewis F, Bartell A, Piercy J, Kissane DW (2008) How do-not-resuscitate orders are utilized in cancer patients: timing relative to death and communication-training implications. Palliat Support Care 6:341–348PubMedCrossRef
6.
go back to reference Miyashita M, Morita T, Sato K, Hirai K, Shima Y, Uchitomi Y (2008) Good death inventory: a measure for evaluating good death from the bereaved family member’s perspective. J Pain Symptom Manage 35:486–498PubMedCrossRef Miyashita M, Morita T, Sato K, Hirai K, Shima Y, Uchitomi Y (2008) Good death inventory: a measure for evaluating good death from the bereaved family member’s perspective. J Pain Symptom Manage 35:486–498PubMedCrossRef
7.
go back to reference Morita T, Hirai K, Sakaguchi Y, Maeyama E, Tsuneto S, Shima Y (2004) Measuring the quality of structure and process in end-of-life care from the bereaved family perspective. J Pain Symptom Manage 27:492–501PubMedCrossRef Morita T, Hirai K, Sakaguchi Y, Maeyama E, Tsuneto S, Shima Y (2004) Measuring the quality of structure and process in end-of-life care from the bereaved family perspective. J Pain Symptom Manage 27:492–501PubMedCrossRef
8.
go back to reference Miyashita M, Morita T, Hirai K (2008) Evaluation of end-of-life cancer care from the perspective of bereaved family members: the Japanese experience. J Clin Oncol 26:3845–3852PubMedCrossRef Miyashita M, Morita T, Hirai K (2008) Evaluation of end-of-life cancer care from the perspective of bereaved family members: the Japanese experience. J Clin Oncol 26:3845–3852PubMedCrossRef
9.
go back to reference Connor SR, Teno J, Spence C, Smith N (2005) Family evaluation of hospice care: results from voluntary submission of data via website. J Pain Symptom Manage 30:9–17PubMedCrossRef Connor SR, Teno J, Spence C, Smith N (2005) Family evaluation of hospice care: results from voluntary submission of data via website. J Pain Symptom Manage 30:9–17PubMedCrossRef
10.
go back to reference Takesaka J, Crowley R, Casarett D (2004) What is the risk of distress in palliative care survey research? J Pain Symptom Manage 28:593–598PubMedCrossRef Takesaka J, Crowley R, Casarett D (2004) What is the risk of distress in palliative care survey research? J Pain Symptom Manage 28:593–598PubMedCrossRef
11.
go back to reference Mack JW, Weeks JC, Wright AA, Block SD, Prigerson HG (2010) End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol 28:1203–1208PubMedCrossRef Mack JW, Weeks JC, Wright AA, Block SD, Prigerson HG (2010) End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol 28:1203–1208PubMedCrossRef
12.
go back to reference Jackson VA, Mack J, Matsuyama R et al (2008) A qualitative study of oncologists’ approaches to end-of-life care. J Palliat Med 11:893–906PubMedCrossRef Jackson VA, Mack J, Matsuyama R et al (2008) A qualitative study of oncologists’ approaches to end-of-life care. J Palliat Med 11:893–906PubMedCrossRef
13.
go back to reference von Gunten CF (2008) Oncologists and end-of-life care. J Palliat Med 11:813CrossRef von Gunten CF (2008) Oncologists and end-of-life care. J Palliat Med 11:813CrossRef
14.
go back to reference Peppercorn JM, Smith TJ, Helft PR et al (2011) American Society of Clinical Oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol 29:755–760PubMedCrossRef Peppercorn JM, Smith TJ, Helft PR et al (2011) American Society of Clinical Oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol 29:755–760PubMedCrossRef
15.
go back to reference Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. New Engl J Med 363:733–742PubMedCrossRef Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. New Engl J Med 363:733–742PubMedCrossRef
16.
go back to reference Keating NL, Landrum MB, Rogers SO Jr et al (2010) Physician factors associated with discussions about end-of-life care. Cancer 116:998–1006PubMedCrossRef Keating NL, Landrum MB, Rogers SO Jr et al (2010) Physician factors associated with discussions about end-of-life care. Cancer 116:998–1006PubMedCrossRef
18.
go back to reference Shin DW, Choi JE, Kim JH et al (2011) What is the best practical survey method for the comparative assessment of palliative care services: results from a national quality assessment project in Korea. J Pain Symptom Manage 42:251–264PubMedCrossRef Shin DW, Choi JE, Kim JH et al (2011) What is the best practical survey method for the comparative assessment of palliative care services: results from a national quality assessment project in Korea. J Pain Symptom Manage 42:251–264PubMedCrossRef
19.
go back to reference Hui D, Mori M, Parson HA, Kim SH, Li Z, Damani S, Bruera E (2011) The lack of standard definitions in the supportive and palliative oncology literature. J Pain Symptom Manage 43:582–592PubMedCrossRef Hui D, Mori M, Parson HA, Kim SH, Li Z, Damani S, Bruera E (2011) The lack of standard definitions in the supportive and palliative oncology literature. J Pain Symptom Manage 43:582–592PubMedCrossRef
Metadata
Title
In-advance end-of-life discussions and the quality of inpatient end-of-life care: a pilot study in bereaved primary caregivers of advanced cancer patients
Authors
Masanori Mori
Donna Ellison
Takamaru Ashikaga
Ursula McVeigh
Allan Ramsay
Steven Ades
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 2/2013
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1581-x

Other articles of this Issue 2/2013

Supportive Care in Cancer 2/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine